Skip to main content
Discover what's not being covered
Published • loading... • Updated

Haemonetics Corporation (NYSE:HAE) Stock Rated "Moderate Buy" by Wall Street Analysts

Summary by MarketBeat
Haemonetics Corporation (NYSE:HAE - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven analysts that are covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one h

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Tuesday, October 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal